Perspective Newsletter


If you would like to receive Perspective - our monthly newsletter – which brings you all of our latest news and views as well as interviews and opinion pieces then please follow the link below...

Read more

Pharmaceutical industry set for M&A uptick, says report

17 February 2011

An uptick in mergers and acquisitions (M&As) is expected within the generic pharmaceutical industry, a report has forecast.

According to the document Gaining Market Share in the Generic Drug Industry Through Acquisitions and Partnerships, released by Thomson Reuters, generics firms will look to mergers to expand and achieve economies of scale.

"Pricing pressures in established generics markets have forced the industry to look for economies of scale in manufacturing and opportunities in emerging markets," commented Kate Kuhrt, director of Generics and API intelligence at Thomson Reuters.

She added that many firms are looking at deals to achieve growth as opposed to organic development.

Should this pattern continue, companies might seek to expand interim manager recruitment as they look to streamline their activities with those of the firms they merge with.

Head of UK equities at Royal London Asset Management Jane Coffey recently predicted an upswing in M&As among British companies during 2011.

Odgers Interim are UK leaders in Interim Management solutions for the Commercial Sector. We have offices in London, Birmingham, Leeds, Manchester, Glasgow, Aberdeen and Cardiff as well as over 50 offices globally. We are the only Interim Management providers who are part of a top tier international executive search firm. We work closely with our executive search colleagues to find candidates who can offer short term solutions with long term benefits. 

Categories: Commercial


No comments have yet been posted, be the first to comment by using the form below: